Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Surgery|December 14, 2001
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomographyM S Cohen, N Arslan, F Dehdashti, et al.Radiology|January 1, 1993
Brain metastases from non-central nervous system tumors: evaluation with PETL K Griffeth, K M Rich, F Dehdashti, et al.Radiology|July 1, 1996
Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucoseF Dehdashti, B A Siegel, L K Griffeth, et al.Radiology|January 1, 1992
PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucoseL K Griffeth, F Dehdashti, A H McGuire, et al.Radiology|June 1, 1996
Invasive breast cancer: mammographic measurementF L Flanagan, M B McDermott, P T Barton, et al.AJR. American Journal of Roentgenology|February 1, 1997
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomographyF L Flanagan, F Dehdashti, B A Siegel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumorsC J Anderson, F Dehdashti, P D Cutler, et al.The Annals of Thoracic Surgery|October 6, 1997
Improvement in staging of esophageal cancer with the addition of positron emission tomographyM I Block, G A Patterson, R S Sundaresan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinomaA H McGuire, F Dehdashti, B A Siegel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomasF Dehdashti, A H McGuire, H F Van Brocklin, et al.Pageof 4